HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jett, G. K. Articles by Abel, P. W. Search for Related Content PubMed PubMed Citation Articles by Jett, G. K. Articles by Abel, P. W.

The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 977-982, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Inhibition of human internal mammary artery contractions. An in vitro study of vasodilators

GK Jett, RA Guyton, CR Hatcher Jr and PW Abel
Department of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Crawford W. Long Memorial Hospital, Emory University, Atlanta, Ga.

The internal mammary artery is currently the preferred conduit for myocardial revascularization; however, perioperative vasospasm of the internal mammary artery may limit its use as a bypass graft. The ability of various vasodilators to inhibit internal mammary artery contraction was investigated with the use of discarded segments of human internal mammary artery not used in coronary artery bypass grafting. Ring segments of human internal mammary arteries were suspended on strain gauges in muscle baths containing 37 degrees C Krebs solution for measurement of isometric tension in vitro. Arterial contraction was stimulated by elevating the extracellular potassium concentration to 70 mmol/L or by exposure to a 10 mumol/L concentration of norepinephrine, and inhibition of contraction by vasodilators was measured. The order of potency to inhibit potassium-induced contraction was as follows: nifedipine > verapamil > nitroprusside > papaverine. At maximal effective doses, nifedipine, verapamil, and papaverine almost completely inhibited potassium-induced contraction, whereas nitroprusside inhibited contraction by only 55%. When norepinephrine was used to contract the arteries, a biphasic relaxation curve was seen with nifedipine, but not with other vasodilator drugs. The order of potency to inhibit norepinephrine-induced contraction was as follows: nifedipine > nitroprusside > verapamil > papaverine. Maximal inhibition of norepinephrine contraction by these vasodilators ranged from 68% to 95%. Nitroglycerin, isoproterenol, and adenosine produced little or no inhibition of internal mammary artery contraction caused by potassium or norepinephrine. Although nifedipine was the most potent vasodilator, papaverine produced the greatest maximal inhibition of both potassium- and norepinephrine-induced contraction of human internal mammary artery.

This article has been cited by other articles:

				H. B. Barner Operative Treatment of Coronary Atherosclerosis Ann. Thorac. Surg., April 1, 2008; 85(4): 1473 - 1482. [Abstract] [Full Text] [PDF]

				M. Bahcivan, F. Kolbakir, H. Karamustafa, and H T. Keceligil Endothoracic Papaverine Application for Internal Thoracic Artery Harvest Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 234 - 237. [Abstract] [Full Text] [PDF]

				D. S. Girard, J. P. Sutton III, T. H. Williams, A. J. Crumbley III, J. L. Zellner, J. M. Kratz, and F. A. Crawford Papaverine Delivery to the Internal Mammary Artery Pedicle Effectively Treats Spasm Ann. Thorac. Surg., October 1, 2004; 78(4): 1295 - 1298. [Abstract] [Full Text] [PDF]

				K. A. Tanaka, F. Szlam, N. Katori, A. Tsuda, and J. H. Levy In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery Br. J. Anaesth., August 1, 2004; 93(2): 257 - 262. [Abstract] [Full Text] [PDF]

				M. Nili, A. Stamler, J. Sulkes, and B. A. Vidne Preparation of the internal thoracic artery by vasodilator drugs: is it really necessary?: A randomized double-blind placebo-controlled clinical study Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 560 - 563. [Abstract] [Full Text] [PDF]

				F. Bilgen, M. F. Yapici, A. SerbetcioGlu, I. A. Tarhan, T. Coruh, and A. Ozler Effect of Normothermic Papaverine to Relieve Intraoperative Spasm of the Internal Thoracic Artery Ann. Thorac. Surg., September 1, 1996; 62(3): 769 - 771. [Abstract] [Full Text]

				R. Gitter, J. M. Anderson Jr, and G. K. Jett Influence of Milrinone and Norepinephrine on Blood Flow in Canine Internal Mammary Artery Grafts Ann. Thorac. Surg., May 1, 1996; 61(5): 1367 - 1371. [Abstract] [Full Text]

				J. D. Fonger, X. M. Yang, R. A. Cohen, C. C. Haudenschild, and R. J. Shemin Human Mammary Artery Endothelial Sparing With Fibrous Jaw Clamping Ann. Thorac. Surg., September 1, 1995; 60(3): 551 - 555. [Abstract] [Full Text]

				G.-W. He, T. E. Acuff, C.-Q. Yang, W. H. Ryan, and M. J. Mack Middle and proximal sections of the human internal mammary artery are not "passive conduits" J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 741 - 746. [Abstract] [Full Text]

				G. K. Jett The in vitro response of human internal mammary artery to vasodilators J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1156 - 1157. [Full Text]

				G. J. Cooper and T. J. Locke The in vitro response of human internal mammary artery to vasodilators J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1155 - 1156. [Full Text]